AVTR - Avantor: Punished Enough - Time To Buy A Misunderstood Healthcare Name - Behind The Idea
This article was selected to be shared with PRO subscribers, who also got 7 days' exclusive access to Viceni Investing's original Top Idea on Avantor (AVTR). Viceni Investing is an individual investor and retired sell-side analyst rated top 10 by Institutional Investor magazine. Find out more about PRO here.
Seeking Alpha: Can you briefly summarize your bullish thesis for readers who may not have seen it yet?
Viceni Investing: AVTR is a high-quality company providing essential supplies to labs and manufacturers within industries such as pharma/biotech, hospitals, diagnostics, academia, and a host of industrial